{{Rsnum
|rsid=3832406
|Orientation=plus
|geno1=(-;-)
|geno2=(-;ATT)
|geno3=(ATT;ATT)
|Chromosome=6
|position=150898848
|Gene=MTHFD1L
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=MTHFD1L
}}{{PMID Auto
|PMID=19777576
|Title=A common variant in MTHFD1L is associated with neural tube defects and mRNA splicing efficiency
|OA=1
}}

{{PharmGKB
|RSID=rs3832406
|Name_s=c.781-6823ATT(7-9), MTHFD1:ATT repeat, deletion insertion in intron 7
|Gene_s=MTHFD1L
|Feature=
|Evidence=PubMed ID:19777576
|Annotation=Risk or phenotype-associated allele: ATT(8) Phenotype: The ATT(8) allele was associated with decreased risk for neural tube defects whereas the ATT(7) allele was associated with increased risk. This variant is also associated with alternative splicing. Study size: 1,705 case families Study population/ethnicity: Mothers, fathers and affected offspring of families with a child with a neural tube defect, Ireland. Significance metric(s): p = 0.002 (logistic regression); p = 0.001 (transmission disequilibrium) Type of association: CO; FA
|Drugs=
|Drug Classes=
|Diseases=Neural Tube Defects
|Curation Level=Curated
|PharmGKB Accession ID=PA165291539
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}